Evidence map›Paper›PMID 35705899›Full record

ArticleBMC anesthesiology2022

Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome.

Christian Bime, Nancy G Casanova, Sara M Camp, Radu C Oita, Juliet Ndukum, Vivian Reyes Hernon, Dong Kyu Oh, Yansong Li, Phil J Greer, David C Whitcomb and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC anesthesiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis.American journal of respiratory cell and molecular biology · 2025
    Article
  5. Article
  6. Predictive modeling of ARDS mortality integrating biomarker/cytokine, clinical and metabolomic data.Translational research : the journal of laboratory and clinical medicine · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  17. Review
  18. Angiopoietin-Like Protein 2 Is Increased in Obese Mouse Models of Lung Injury.Computational and mathematical methods in medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Christian Bime *Department of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Nancy G Casanova *Department of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Sara M CampDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Radu C OitaDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Juliet NdukumDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Vivian Reyes HernonDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.
Dong Kyu OhUniversity of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Yansong LiUS Army Institute of Surgical Research, San Antonio, TX, USA.
Phil J GreerUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
David C WhitcombUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Georgios I PapachristouUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Joe G N GarciaDepartment of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA. skipgarcia@arizona.edu.
University of Arizona · USUniversity of Pittsburgh · USAsan Medical Center · KRThe Ohio State University · USUnited States Army Institute of Surgical Research · US

Funding

Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI Joe G. N. Garcia · 2016 to 2026
$24.4M
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)R42HL145930 · NHLBI · AQUALUNG THERAPEUTICS CORP. · PI GARCIA, JOE G. N. · 2019 to 2021
$1.7M
SELPLG as a candidate gene in Acute Respiratory Distress SyndromeK08HL141623 · NHLBI · UNIVERSITY OF ARIZONA · PI BIME, CHRISTIAN · 2018 to 2022
$863k
The CRIT-ICU Biomarker Panel for Stratification of Mortality Risk in ARDS PatientsR41HL147769 · NHLBI · AQUALUNG THERAPEUTICS CORP. · PI GARCIA, JOE G. N. · 2019 to 2019
$225k
NHLBI NIH HHS K08 HL141623NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R41 HL147769NHLBI NIH HHS R42 HL145930
6 · The paper itself

Abstract

backgroundNicotinamide phosphoribosyltransferase (NAMPT) exhibits dual functionality - as an intracellular enzyme regulating nicotinamide adenine dinucleotide metabolism and as an extracellular secreted protein (eNAMPT) to function as a cytokine regulator of innate immunity via binding to Toll-Like receptor 4 and NF-κB activation. In limited preclinical and clinical studies, eNAMPT was implicated in the pathobiology of acute respiratory distress syndrome (ARDS) suggesting that eNAMPT could potentially serve as a diagnostic and prognostic biomarker. We investigated the feasibility of circulating eNAMPT levels to serve as a biomarker in an expanded cohort of patients with ARDS and ARDS-predisposing conditions that included acute pancreatitis, sepsis, and trauma with comparisons to controls.

methodsA total of 671 patients and 179 healthy controls were included in two independent cohorts. Plasma and serum eNAMPT levels were quantified using one of two complementary Enzyme-linked Immunosorbent Assays. After log base 2 variance stabilizing transformation of plasma/serum eNAMPT measurements, differences between healthy controls and each disease cohort were compared using linear regression or a generalized estimating equation (GEE) model where applicable. Complementary analyses included sensitivity, specificity, positive predictive values, negative predictive values, and the area under the receiver operating curve.

resultsCompared to controls, circulating eNAMPT levels were significantly elevated in subjects with acute pancreatitis, sepsis, trauma, and ARDS (all p < 0.01). In the acute pancreatitis cohort, circulating eNAMPT levels positively correlated with disease severity (p < 0.01).

conclusionsCirculating eNAMPT levels are novel biomarker in the critically ill with acute pancreatitis, sepsis, trauma, and/or ARDS with the potential to reflect disease severity.

Indexed as

PancreatitisRespiratory Distress SyndromeSepsisAcute DiseaseBiomarkersCritical IllnessHumansBiomarkersARDSBiomarkereNAMPTNAMPTPancreatitisSepsisTrauma

Identifiers

PMID35705899
PMCPMC9198204
OpenAlexW4282925210

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.